Ivermectin

Les informations publiées sur ce site reprennent en version française les informations notamment diffusées sur le site de la FLCCC. 

Elles ne constituent en aucun cas une recommandation médicale. Consultez votre médecin traitant et suivez ses recommandations avant d’envisager de prendre un traitement, suivez les directives des autorités de santé et évitez l’auto-médication. Les traductions peuvent contenir des erreurs, les textes du site original font foi. Site indépendant de la FLCCC, sans conflit ni lien d’intérêt.

Ivermectin is effective for COVID-19: real-time meta analysis of 50 studies
Covid Analysis, Nov 26, 2020 (Version 58, Apr 10, 2021)

Fiche d’informations synthétisant les données scientifiques concernant l’ivermectine dans le traitement de la Covid-19.

Article 1: 

Italian-led Ivermectin Meta-Analysis: Is it Time to Consider the Generic Low Cost Option to Help Treat COVID-19? A group of six critical care physicians and researchers, four of who are affiliated with IRCCS (IRCCS Ospedale San Raffaele) San Raffaele Scientific Institute in Milan, Italy, recently conducted a meta-analysis looking into ivermectin and along the way asking a highly uncomfortable question as to whether suspect claims about safety for commonly available drugs in fact are driven by a deep-seated, intensive fear of failure among the scientific and medical community. The idea that, with tens of billions have been invested into a particular approach, anything that gets in the way could be deemed recognition of failure. Story Link: https://trialsitenews.com/italian-led... 

Article 2: 

Emory Discovered Drug May Take Over $3+ Billion Market Now Going to Remdesivir EIDD-2801, the Merck drug now known as Molnupiravir, can be administered orally as a pill in an outpatient setting. Now, as we have identified here at TrialSite News, The big gap drug companies have yet to fill with regards to COVID-19 is treatment at early onset of the SARS-CoV-2 virus, during the mild to moderate stage. Instead, what most commonly happens today, is folks diagnosed positive are often simply sent home most of the time with no treatment. 

présentation sous-titrée en français de Andrew Hill

Le Dr Gérard Maudrux pousse un énorme coup de gueule sur la question des traitements contre le Covid-19, au micro d'André Bercoff.

SIGN THE PETITION: https://www.change.org/p/nih-update-y... 

Marik Protocol: https://www.evms.edu/media/evms_publi... 

InVitro Ivermectin study: https://www.ncbi.nlm.nih.gov/pmc/arti... 

Argentina Study: https://media.marinomed.com/8b/7a/c7/... 

France Nursing Home Study: https://translate.google.com/translat... 

Egypt study: https://assets.researchsquare.com/fil... 

Population study in Africa: https://www.ncbi.nlm.nih.gov/pmc/arti... 

Epidemiological Data from Peru and other countries: https://covid19criticalcare.com/i-mas... 

FLCCC summary statement on Ivermectin: https://covid19criticalcare.com/wp-co...

This is our recommended approach to COVID-19 based on the best (and most recent) literature. This is a highly dynamic topic; therefore, we will be updating the guideline as new information emerges.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website.

WhiteBoard Style discussion on a new Perspective and Review published exploring another possible pathway in which SARS-CoV-2 may be leading to micro and macrothrombi; through the spike proteins interaction with the CD147 receptor on red blood cells, platelets, endothelial cells, and more. It is postulated that this leads to the aggregation and subsequent obstruction of blood vessels. Interestingly, this author proposes that maybe it is Ivermectin's inhibition of this interaction between the spike protein and CD147 receptor that leads to its potential efficacy! Could this be another reason we have seen data supporting the efficacy of Ivermectin for COVID-19? Check out the video to find out more! To be clear, this video is based on a Perspective paper, which is strictly hypothetical! This is not a study that is coming up with an objective conclusion!

Please note a correction on date mentioned in podcast: May is the correct date instead of March 

Today we have the pleasure of introducing #DrJeanJacquesRajter a Broward Health Medical Center physician and his wife Dr. Juliana Cepelowicz Rajter, in Florida. We covered a story about Dr. Rajter back in April, where they were “pioneering” the use of the anti-parasitic drug ivermectin on COVID-19 patients. Today, we talk to with them both about the results from the Sunshine state, and what the future holds. 

#ivermectin